Stage III Grade 1 Follicular Lymphoma Terminated Phase 2 Trials for Busulfan (DB01008)

IndicationStatusPhase
DBCOND0028628 (Stage III Grade 1 Follicular Lymphoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01044745Rituximab in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerTreatment